Weave Bio is an AI-native platform transforming regulatory workflows and accelerating how novel therapies reach patients faster.
Weave has raised $20.0M in total funding. The most recent round was Series A. The last funding was announced in October 2025.
Weave's investors include U.S. Venture Partners, TMV, Innovation Endeavors, Character, Pareto Holdings.
Weave is headquartered in San Francisco, United States.
Weave Bio is an AI-native platform transforming regulatory workflows and accelerating how novel therapies reach patients faster.
Weave is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Weave — Funding & Investors." VCBacked, October 16, 2025, https://www.vcbacked.co/company/weave. Accessed September 2, 2026.
VCBacked. (2025). Weave — Funding & Investors. Retrieved September 2, 2026, from https://www.vcbacked.co/company/weave
{{cite web |title=Weave — Funding & Investors |url=https://www.vcbacked.co/company/weave |website=VCBacked |access-date=September 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated